Morgan Stanley Raises Ventas (VTR) Price Target on Improving Occupancy Outlook

Core Insights - Ventas, Inc. (NYSE:VTR) is recognized as one of the 14 best real estate stocks to buy according to hedge funds [1] - Morgan Stanley raised its price target for Ventas to $90 from $80, maintaining an Equal Weight rating, citing strong quarterly performance and expectations for further growth in 2026 [2] - The company's Q4 2025 earnings call highlighted a standout year, driven by its 1-2-3 Strategy focused on senior housing, with strong demand and limited new supply [3] Financial Performance - Normalized FFO per share increased by 9% for the year, while same-store SHOP cash NOI rose by 15%, indicating robust performance in the senior housing sector [4] - Total shareholder returns for Ventas reached 35% in 2025, outperforming industry benchmarks and the broader S&P 500 [4] Company Overview - Ventas, Inc. is a healthcare-focused REIT with a diversified portfolio, owning approximately 1,400 properties across North America and the United Kingdom, including senior housing communities and various healthcare facilities [5]